Cannabis-induced psychosis associated with high potency “wax dabs”
Section snippets
Funding
The authors report no source of funding for this project.
Contributors
Joseph M. Pierre, M.D.
Michael Gandal, M.D., Ph.D.
Maya Son.
Conflicts of interest
The authors report no conflicts of interest in relation to this manuscript.
Acknowledgements
The authors report no acknowledgements in relation to this manuscript.
References (10)
- et al.
“Time for dabs”: Analyzing Twitter data on marijuana concentrates across the U.S.
Drug Alcohol Depend.
(2015) - et al.
Proportion of patients in South London with first-episode psychosis attributable to use of high potency cannabis: a case–control study
Lancet Psychiatry
(2015) - et al.
A new method of cannabis ingestion: the danger of dabs?
Addict. Behav.
(2014) - et al.
Cannabis use and risk of psychotic or affective mental health outcomes: A systematic review
Lancet
(2007) - et al.
Honey oil burns: A growing problem
J. Burn. Care. Res.
(2015)
There are more references available in the full text version of this article.
Cited by (63)
Impact of adolescent THC exposure on later adulthood: Focus on mesocorticolimbic function and behaviors
2022, Cannabis and the Developing BrainThe chemistry and toxicology of vaping
2021, Pharmacology and TherapeuticsPrice and product variation in Washington's recreational cannabis market
2021, International Journal of Drug PolicyModes of marijuana use – smoking, vaping, eating, and dabbing: Results from the 2016 BRFSS in 12 States
2020, Drug and Alcohol Dependence
Published by Elsevier B.V.